Literature DB >> 24948434

Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality.

Martin Wolkewitz1, Martin Schumacher2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24948434     DOI： 10.1016/S2213-2600(14)70115-8

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN： 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  3 in total

1.  Neuraminidase Inhibitors and Hospital Mortality in British Patients with H1N1 Influenza A: A Re-Analysis of Observational Data.

Authors:  Martin Wolkewitz; Martin Schumacher
Journal:  PLoS One       Date:  2016-09-01       Impact factor: 3.240

2.  Evidence synthesis and decision modelling to support complex decisions: stockpiling neuraminidase inhibitors for pandemic influenza usage.

Authors:  Samuel I Watson; Yen-Fu Chen; Jonathan S Nguyen-Van-Tam; Puja R Myles; Sudhir Venkatesan; Maria Zambon; Olalekan Uthman; Peter J Chilton; Richard J Lilford
Journal:  F1000Res       Date:  2016-09-12

3.  Influenza-associated mortality in hospital care: a retrospective cohort study of risk factors and impact of oseltamivir in an English teaching hospital, 2016 to 2017.

Authors:  Mark Reacher; Ben Warne; Lucy Reeve; Neville Q Verlander; Nicholas K Jones; Kyriaki Ranellou; Silvana Christou; Callum Wright; Saher Choudhry; Maria Zambon; Clare Sander; Hongyi Zhang; Hamid Jalal
Journal:  Euro Surveill       Date:  2019-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.